AU-409: a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma

Written By Yolandi Stanek

Oral Presentation at the 13th Annual Conference of the International Liver Cancer Association Highlights Promising Antitumor Activity in Preclinical Cancer Model and HCC Cell Lines

Yolandi Stanek https://helloyo.com
Previous

Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases
Next

Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia